Bollhagen, Alina https://orcid.org/0000-0003-3592-8282
Whipman, James
Coelho, Ricardo https://orcid.org/0000-0002-9340-3612
Heinzelmann-Schwarz, Viola
Jacob, Francis https://orcid.org/0000-0002-0446-1942
Bodenmiller, Bernd https://orcid.org/0000-0002-6325-7861
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_205007)
U.S. Department of Health & Human Services | National Institutes of Health (5R01DK131059-04)
EC | Horizon 2020 Framework Programme (866074)
Article History
Received: 31 January 2025
Accepted: 26 September 2025
First Online: 30 October 2025
Competing interests
: B.B. has founded and is a shareholder and member of the board of Navignostics, a precision oncology spin-off from the University of Zurich. The other authors declare no competing interests.